Hypogonadism, Male clinical trials at UCSF
1 research study open to eligible people
Hypogonadism, male means the body makes less testosterone than normal. UCSF is studying a year of testosterone therapy plus a two-year extension in adolescents. UCSF is tracking safety, blood levels, and symptom measures.
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
open to eligible males ages 12-17
This is a 52-week open label single arm study + 24-Month long-term safety extension to investigate the effects of XYOSTED, as testosterone replacement therapy, on adolescent males with either primary or secondary hypogonadism. The study aims to determine the effectiveness of XYOSTED measured by continuation or induction of puberty in addition to XYOSTED dosage, safety and testosterone levels.
San Francisco, California and other locations
Last updated: